CD274 and esophageal squamous cell carcinoma: Similarly, ATTRACTION-3 included patients with unresectable advanced or recurrent esophageal SCC (regardless of PD-L1 expression) refractory or intolerant to one previous fluoropyrimidine-based and platinum-based chemotherapy [38].